• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国大陆非结核分枝杆菌感染的流行情况:系统评价和荟萃分析。

The prevalence of non-tuberculous mycobacterial infections in mainland China: Systematic review and meta-analysis.

机构信息

National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.

Medical Library of Chinese People's Liberation Army, 59th, Middle Section West 4th Ring, Beijing, 100039, China.

出版信息

J Infect. 2016 Dec;73(6):558-567. doi: 10.1016/j.jinf.2016.08.020. Epub 2016 Oct 4.

DOI:10.1016/j.jinf.2016.08.020
PMID:27717784
Abstract

Despite increasing attention towards the non-tuberculous mycobacterial (NTM) diseases, the overall epidemiological information remains unavailable for China. A systematic review and meta-analysis was conducted using data of 105 qualified publications from Chinese mainland. The assay demonstrated that the prevalence of NTM infections among tuberculosis suspects was 6.3% (5.4%-7.4%) in mainland, while the Southeastern region had the highest NTM prevalence at 8.6% (7.1%-10.5%). In Northern China, slow growing mycobacteria (SGM) consistituted 63.7% of all the NTM isolates, while this rate in Southern China was 53.0%. More rapid growing mycobacteria (RGM) were present in southern China than the northern (χ = 57.996, P < 0.001). According to the coastal provinces' data (from north to south), the NTM prevalence rate and the number of isolated NTM species increased apparently in accordance with geographic latitude. The information obtained in this assay will facilitate the NTM disease diagnosis and screening policy making in China.

摘要

尽管非结核分枝杆菌(NTM)疾病越来越受到关注,但中国的整体流行病学信息仍然缺乏。本研究使用中国大陆 105 篇合格出版物的数据进行了系统评价和荟萃分析。结果表明,在中国大陆,肺结核疑似患者中 NTM 感染的患病率为 6.3%(5.4%-7.4%),而东南部地区的 NTM 患病率最高,为 8.6%(7.1%-10.5%)。在北方,慢生长分枝杆菌(SGM)占所有 NTM 分离株的 63.7%,而在南方这一比例为 53.0%。与北方相比,南方的快速生长分枝杆菌(RGM)更为常见(χ=57.996,P<0.001)。根据沿海省份(从北到南)的数据,NTM 患病率和分离的 NTM 种类数量随着地理纬度的增加而明显增加。本研究结果将有助于中国 NTM 疾病的诊断和筛查政策制定。

相似文献

1
The prevalence of non-tuberculous mycobacterial infections in mainland China: Systematic review and meta-analysis.中国大陆非结核分枝杆菌感染的流行情况:系统评价和荟萃分析。
J Infect. 2016 Dec;73(6):558-567. doi: 10.1016/j.jinf.2016.08.020. Epub 2016 Oct 4.
2
Evaluation of the Standard M10 MTB/NTM Molecular Test for the Rapid Identification of Tuberculous and Nontuberculous Mycobacteria in Liquid Cultures.用于液体培养中快速鉴定结核分枝杆菌和非结核分枝杆菌的标准M10 MTB/NTM分子检测方法的评估
Pathogens. 2025 May 22;14(6):517. doi: 10.3390/pathogens14060517.
3
Clinical presentation and treatment outcomes of extrapulmonary nontuberculous mycobacterial infections with rapid and slow growth rates in Cali, Colombia.哥伦比亚卡利市肺外非结核分枝杆菌感染的临床表现及快速和缓慢生长率的治疗结果
BMC Infect Dis. 2025 Mar 31;25(1):444. doi: 10.1186/s12879-025-10681-4.
4
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.全球非结核分枝杆菌肺部感染的趋势:一项系统评价。
Int J Infect Dis. 2022 Dec;125:120-131. doi: 10.1016/j.ijid.2022.10.013. Epub 2022 Oct 13.
5
Vertebral osteomyelitis caused by non-tuberculous mycobacteria: Predisposing conditions and clinical characteristics of six cases and a review of 63 cases in the literature.非结核分枝杆菌引起的脊椎骨骨髓炎:6 例病例的诱发条件和临床特征及文献中的 63 例病例回顾。
Infect Dis (Lond). 2016 Jul;48(7):509-16. doi: 10.3109/23744235.2016.1158418. Epub 2016 Mar 22.
6
Non-tuberculous mycobacteria disease pre-lung transplantation: A systematic review of the treatment regimens and duration pre- and post-transplant.肺移植前的非结核分枝杆菌病:对移植前后治疗方案及疗程的系统评价
Transplant Rev (Orlando). 2023 Dec;37(4):100800. doi: 10.1016/j.trre.2023.100800. Epub 2023 Oct 7.
7
Prevalence of nontuberculous mycobacteria in a tertiary hospital in Beijing, China, January 2013 to December 2018.2013 年 1 月至 2018 年 12 月期间,中国北京一家三级医院中非结核分枝杆菌的流行情况。
BMC Microbiol. 2020 Jun 12;20(1):158. doi: 10.1186/s12866-020-01840-5.
8
Prevalence and speciation of non-tuberculous mycobacteria among pulmonary and extrapulmonary tuberculosis suspects in South India.在印度南部,疑似肺结核和肺外结核患者中非结核分枝杆菌的流行情况和种型分布。
J Infect Public Health. 2021 Mar;14(3):320-323. doi: 10.1016/j.jiph.2020.12.027. Epub 2021 Feb 19.
9
Microbiological and Clinical Outcomes of Treating Non-Mycobacterium Avium Complex Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-Analysis.治疗非结核分枝杆菌肺病的微生物学和临床结局:系统评价和荟萃分析。
Chest. 2017 Jul;152(1):120-142. doi: 10.1016/j.chest.2017.04.166. Epub 2017 Apr 28.
10
[Evaluation of the distribution of non-tuberculous mycobacteria strains isolated in National Tuberculosis Reference Laboratory in 2009-2010, Turkey].[2009 - 2010年土耳其国家结核病参考实验室分离的非结核分枝杆菌菌株分布评估]
Mikrobiyol Bul. 2012 Oct;46(4):560-7.

引用本文的文献

1
Simultaneous detection and differentiation of and nontuberculous mycobacteria in smear-negative sputum by a multiplex PCR assay: a clinical feasibility study.通过多重聚合酶链反应检测方法同时检测和鉴别涂片阴性痰液中的结核分枝杆菌和非结核分枝杆菌:一项临床可行性研究。
Microbiol Spectr. 2025 Jul;13(7):e0231624. doi: 10.1128/spectrum.02316-24. Epub 2025 May 30.
2
Limited predictive power of known resistance genes for phenotypic drug resistance in clinical complex from Beijing in China.中国北京临床复杂样本中已知耐药基因对表型耐药的预测能力有限。
Antimicrob Agents Chemother. 2025 Jul 2;69(7):e0184724. doi: 10.1128/aac.01847-24. Epub 2025 May 27.
3
Interpreting diagnosis outcomes for tuberculosis to timely and reliably predict non-tuberculosis mycobacteria isolation.
解读肺结核诊断结果,以便及时、可靠地预测非结核分枝杆菌分离情况。
J Med Microbiol. 2025 Apr;74(4). doi: 10.1099/jmm.0.002009.
4
Essential Oils and their Active Constituents Effective against Non-growing Mycobacterium intracellulare.对非增殖性胞内分枝杆菌有效的精油及其活性成分。
BMC Complement Med Ther. 2025 Mar 31;25(1):122. doi: 10.1186/s12906-025-04855-5.
5
The antimicrobial activity of linezolid against unconventional pathogens.利奈唑胺对非传统病原体的抗菌活性。
PeerJ. 2025 Feb 12;13:e18825. doi: 10.7717/peerj.18825. eCollection 2025.
6
Population genetic analysis of clinical complex strains in China.中国临床复杂菌株的群体遗传学分析。
Front Cell Infect Microbiol. 2025 Jan 20;14:1496896. doi: 10.3389/fcimb.2024.1496896. eCollection 2024.
7
Clinical analysis and risk factors associated with poor prognosis in nontuberculous mycobacterial infection.非结核分枝杆菌感染预后不良的临床分析及相关危险因素
Virulence. 2025 Dec;16(1):2459313. doi: 10.1080/21505594.2025.2459313. Epub 2025 Feb 3.
8
Development and evaluation of multiplex real-time PCR for rapid identifying major pathogenic mycobacteria from pulmonary and extrapulmonary clinical samples in eastern China.用于快速鉴定中国东部地区肺部和肺外临床样本中主要致病性分枝杆菌的多重实时PCR的开发与评估
Heliyon. 2024 Dec 27;11(1):e41384. doi: 10.1016/j.heliyon.2024.e41384. eCollection 2025 Jan 15.
9
Treatment outcomes in NTM-PD in a high TB burden context.高结核病负担背景下非结核分枝杆菌肺病的治疗结果
IJTLD Open. 2024 Dec 1;1(12):547-555. doi: 10.5588/ijtldopen.24.0413. eCollection 2024 Dec.
10
Case report: A rare case of meningoencephalitis caused by .病例报告:一例由……引起的罕见脑膜脑炎病例。 (注:原文中“caused by”后面内容缺失)
Front Med (Lausanne). 2024 Oct 23;11:1416272. doi: 10.3389/fmed.2024.1416272. eCollection 2024.